Critical Care Update 2021 - Subhash Todi, Dhruva Chaudhry, Deepak Govil, Subhal Bhalchandra Dixit

Critical Care Update 2021

Buch | Softcover
458 Seiten
2021 | 3rd Revised edition
Jaypee Brothers Medical Publishers (Verlag)
978-93-90595-87-7 (ISBN)
54,85 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken

Subhash Todi MD MRCP Director, Department of Critical Care, Advanced Medicare Research Institute, Kolkata, West Bengal, India Deepak Govil MD EDIC FICCM FCCM Director, Institute of Critical Care and Anesthesia, Medanta - The Medicity, Gurugram, Haryana, India Dhruva Chaudhry MD DNB DM Professor and Head, Department of Pulmonary and Critical Care Medicine, Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India Subhal Bhalchandra Dixit MD IDCCM FICCM FICP FCCM Consultant, Critical Care and Director, ICU, Department of Critical Care, Sanjeevan and MJM Hospitals, Pune, Maharashtra, India

Section 1: Respiratory

1 Monitoring respiratory drive in spontaneous and mechanically ventilated patients

2 Use misuse and abuse of HFNC

3 Management of complex pleural effusion in ICU

4 ARDS phenotype: Clinical relevance

5 Long term consequences of ARDS its management

6 Diffuse Parenchymal lung disease

7 Patient self-inflicted lung injury: Clinical relevance

8 Role of P.01 in difficult weaning

9 Transpulmonary pressure guided ventilation: Where do we stand?

10 VILI prevention: is mechanical power targeted therapy the ultimate goal

11 Predicting microorganism in VAP: Is Surveillance culture the answer?

12 Effect of critical care illness on sleep

Section 2: Extra corporeal life support

13 Infectious complications in patients on ECMO

14 CPR: To whom and when

15 ECMO in cardiogenic shock: When, and why and to whom?

16 Ventricular assess devices

Section 3: Hemodynamics

17 Cardiovascular coupling (ventricular atrial): everyday relevance in critical care

18 Fluid resuscitation targets in sepsis: Should we stop monitoring MAP

19 Arterial elastance: The renewed interest

20 Perfusion index by pulse oximetry: Utility in ICU

Section 4: Cardiovascular

21 ACLS 2020: What has changed

22 Refractory vasodilatory shock: What's new?

23 Optimizing diuresis in acute decompensated heart failure

24 Predicting intraoperative hypotension

Section 5: Sepsis and Septic shock

25 Vitamins in sepsis B, C, D: Current status

26 Newer antibiotics for community acquired pneumonia

27 Recent advances in diagnosis and management of Candidemia

28 Cytokine blockade: double edge sword

29 Antifungal stewardship

Section 6: Nutrition

30 Personalized feeding in septic patients

31 Risks of overfeeding in ICU

32 Protein versus calories: which is more important?

33 Muscle mass: bedside monitoring and relevance

34 Use of newer technology in ICU nutrition

Section 7: Gastroenterology

35 Diagnosis and management of AKI in liver failure

36 Diarrhoea in immunocompromised patients

37 Cryptic infections in cirrhotic patients

Section 8: USG and ECHO

38 Ultrasound assessment of weaning failure

39 POCUS in Sepsis

40 Role of ultrasound in de-resuscitation

41 Ultrasound guided ventilation

42 Lung ultrasound in COVID: Pearls and pitfalls

Section 9: Renal and electrolytes

43 Drug induced AKI

44 Hyperviscocity syndromes

45 Timing of renal replacement therapy in ICU

46 Monitoring patients on CRRT

47 Urinary electrolyte measurement: When and why

48 Emphysematous pyelonephritis

49 Renal tubular acidosis in ICU: Are we missing it?

Section 10: Neurocritical care

50 Imaging based ischemic stroke management: What should we know

51 Hypoxic ischemic encephalopathy

52 Antibiotic associated neurotoxicity

53 Autoimmune encephalitis

54 Antifibrinolytic therapy in TBI: What do we know?

55 Inhalation sedation in ICU: Is it worth all the effort?

56 Advanced directives in India: Ethical, legal and practical considerations

57 Optimizing availability and quality of cadaveric organs

58 Epidural analgesia in ICU, is it underused

Section 11: COVID related ICU issues

59 Fungal pneumonia, COVID associated fungal

60 COVID breathlessness

61 Multi system cytokine inflammatory syndrome (MCIS)

62 Convalescent plasma therapy

Section 12: Trauma/Perioperative/Toxicology/Burn

63 Perioperative delirium

64 Tranexamic acid: Current use in ICU

65 Optimising antimicrobial use in burns

66 Extracorporal Blood purification in poisoning and drug overdose

Section 13: Quality/Ethics/Organisation/ICU research

67 Communication skills: Tricks of the trade

68 Use of artificial intelligence in ICU

69 Towards safer procedures in ICU

70 Temperature monitoring in the critically ill

71 Critical care pharmacist: An unmet need

72 Post ICU follow up clinic

73 Organ donation: Current guidelines

74 Care of elderly in ICU

75 Post traumatic stress disorder

76 Iatrogenic air embolism

77 Chlorhexadine oral hygiene in ICU: Is it safe?

Section 14: Hematology/Oncology/Obstetrics /Pharmacology

78 Obstetric rapid response team

79 Iron substitution in ICU

80 Vasculitis in ICU

81 Life threatening complication of newer oncological therapies

82 Challenges in glucose monitoring in ICU

83 Detecting relative adrenal insufficiency and diabetes insipidus

Erscheinungsdatum
Verlagsort New Delhi
Sprache englisch
Maße 216 x 279 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Intensivmedizin
Medizin / Pharmazie Medizinische Fachgebiete Notfallmedizin
ISBN-10 93-90595-87-8 / 9390595878
ISBN-13 978-93-90595-87-7 / 9789390595877
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Medikamente, psychoaktive Genussmittel und Drogen

von Jan Dreher

Buch (2024)
Thieme (Verlag)
50,00